PDL Biopharma Sues to Protect Cardene I.V.
An Indian pharmaceutical company has been hit with a patent infringement suit over its efforts to move in on the market for PDL Biopharma Inc.'s hypertension treatment Cardene I.V....To view the full article, register now.
Already a subscriber? Click here to view full article